Another report suggested that intronic mutations in AK9 may act as a disease modifier in combination with RAPSN mutations in limb-girdle congenital myasthenia, but causality or a mechanism of action was not determined (46). This evidence concerns the gene AK9 and congenital myasthenic syndrome.